NKMAX is a biotechnology company focused on developing natural killer (NK) cell therapies for the treatment of cancer and other diseases by enhancing the immune system's ability to target and kill tumor cells.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!